1. Molecular epigenetic dynamics in breast carcinogenesis
   Aadrita Hazra et al, 2021, Archives of Pharmacal Research CrossRef
2. Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
   Ruoning Yang et al, 2022, Molecular Biomedicine CrossRef
3. Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature
   Yan Qin et al, 2021, Aging CrossRef
4. Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
   Fokhrul Hossain et al, 2021, Cancers CrossRef
5. Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer
   Silvia Di Agostino et al, 2022, Non-Coding RNA CrossRef
6. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
   Amal Qattan et al, 2021, Genes CrossRef
7. Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?
   Emma E. Newton et al, 2022, Cancers CrossRef
8. Synthesis, Characterization, and Assessment of Anti-Cancer Potential of ZnO Nanoparticles in an In Vitro Model of Breast Cancer
   Alaa A. A. Aljabali et al, 2022, Molecules CrossRef
9. Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
   Mamta Kumari et al, 2020, Current Cancer Drug Targets CrossRef
10. Cell Cycle and Factors Involved in Inhibition or Progression of Breast Cancer
    Shazia Ali et al, 2020, Breast Cancer Biology CrossRef
11. Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice
    Chih-Hung Guo et al, 2021, Marine Drugs CrossRef
12. Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway
    Shenghan Gao et al, 2023, Drug Design, Development and Therapy CrossRef